These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1224 related items for PubMed ID: 22244827

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Enhanced antitumor efficacy of telomerase-specific oncolytic adenovirus with valproic acid against human cancer cells.
    Watanabe Y, Hashimoto Y, Kagawa S, Kawamura H, Nagai K, Tanaka N, Urata Y, Fujiwara T.
    Cancer Gene Ther; 2012 Nov; 19(11):767-72. PubMed ID: 22956040
    [Abstract] [Full Text] [Related]

  • 3. The antitumor efficacy of IL-24 mediated by E1A and E1B triple regulated oncolytic adenovirus.
    Xiao LL, Wu YM, Qian J, Tan Y, Xie GL, Zhang KJ, Wang YG, Jia XY, Liu XY.
    Cancer Biol Ther; 2010 Aug 01; 10(3):242-50. PubMed ID: 20574150
    [Abstract] [Full Text] [Related]

  • 4. Dual programmed cell death pathways induced by p53 transactivation overcome resistance to oncolytic adenovirus in human osteosarcoma cells.
    Hasei J, Sasaki T, Tazawa H, Osaki S, Yamakawa Y, Kunisada T, Yoshida A, Hashimoto Y, Onishi T, Uno F, Kagawa S, Urata Y, Ozaki T, Fujiwara T.
    Mol Cancer Ther; 2013 Mar 01; 12(3):314-25. PubMed ID: 23315976
    [Abstract] [Full Text] [Related]

  • 5. Modification of the p53 transgene of a replication-competent adenovirus prevents mdm2- and E1b-55kD-mediated degradation of p53.
    Sauthoff H, Pipiya T, Chen S, Heitner S, Cheng J, Huang YQ, Rom WN, Hay JG.
    Cancer Gene Ther; 2006 Jul 01; 13(7):686-95. PubMed ID: 16470212
    [Abstract] [Full Text] [Related]

  • 6. Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model.
    Wang H, Wei F, Li H, Ji X, Li S, Chen X.
    Int J Mol Med; 2013 Feb 01; 31(2):377-85. PubMed ID: 23229955
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. HCCS1-armed, quadruple-regulated oncolytic adenovirus specific for liver cancer as a cancer targeting gene-viro-therapy strategy.
    Xu HN, Huang WD, Cai Y, Ding M, Gu JF, Wei N, Sun LY, Cao X, Li HG, Zhang KJ, Liu XR, Liu XY.
    Mol Cancer; 2011 Nov 01; 10():133. PubMed ID: 22040050
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Advances in adenovirus-mediated p53 cancer gene therapy.
    Tazawa H, Kagawa S, Fujiwara T.
    Expert Opin Biol Ther; 2013 Nov 01; 13(11):1569-83. PubMed ID: 24107178
    [Abstract] [Full Text] [Related]

  • 13. Preclinical evaluation of differentially targeting dual virotherapy for human solid cancer.
    Sakai R, Kagawa S, Yamasaki Y, Kojima T, Uno F, Hashimoto Y, Watanabe Y, Urata Y, Tanaka N, Fujiwara T.
    Mol Cancer Ther; 2010 Jun 01; 9(6):1884-93. PubMed ID: 20501801
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Co-transduction of ribosomal protein L23 enhances the therapeutic efficacy of adenoviral-mediated p53 gene transfer in human gastric cancer.
    Zhang YF, Zhang BC, Zhang AR, Wu TT, Liu J, Yu LF, Wang WX, Gao JF, Fang DC, Rao ZG.
    Oncol Rep; 2013 Oct 01; 30(4):1989-95. PubMed ID: 23933826
    [Abstract] [Full Text] [Related]

  • 16. A novel triple-regulated oncolytic adenovirus carrying p53 gene exerts potent antitumor efficacy on common human solid cancers.
    Wang X, Su C, Cao H, Li K, Chen J, Jiang L, Zhang Q, Wu X, Jia X, Liu Y, Wang W, Liu X, Wu M, Qian Q.
    Mol Cancer Ther; 2008 Jun 01; 7(6):1598-603. PubMed ID: 18566230
    [Abstract] [Full Text] [Related]

  • 17. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
    Idogawa M, Sasaki Y, Suzuki H, Mita H, Imai K, Shinomura Y, Tokino T.
    Clin Cancer Res; 2009 Jun 01; 15(11):3725-32. PubMed ID: 19458054
    [Abstract] [Full Text] [Related]

  • 18. Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells.
    Watanabe T, Hioki M, Fujiwara T, Nishizaki M, Kagawa S, Taki M, Kishimoto H, Endo Y, Urata Y, Tanaka N, Fujiwara T.
    Exp Cell Res; 2006 Feb 01; 312(3):256-65. PubMed ID: 16356494
    [Abstract] [Full Text] [Related]

  • 19. E1A, E1B double-restricted adenovirus with RGD-fiber modification exhibits enhanced oncolysis for CAR-deficient biliary cancers.
    Wakayama M, Abei M, Kawashima R, Seo E, Fukuda K, Ugai H, Murata T, Tanaka N, Hyodo I, Hamada H, Yokoyama KK.
    Clin Cancer Res; 2007 May 15; 13(10):3043-50. PubMed ID: 17505007
    [Abstract] [Full Text] [Related]

  • 20. Biodistribution and safety assessment of bladder cancer specific recombinant oncolytic adenovirus in subcutaneous xenografts tumor model in nude mice.
    Wang F, Wang Z, Tian H, Qi M, Zhai Z, Li S, Li R, Zhang H, Wang W, Fu S, Lu J, Rodriguez R, Guo Y, Zhou L.
    Curr Gene Ther; 2012 Apr 01; 12(2):67-76. PubMed ID: 22384806
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 62.